Ligand id: 7447

Name: peginesatide

No information available.
Summary of Clinical Use
Approved to treat anemia associated with chronic kidney disease (CKD) in dialysis patients. The administered drug contains the acetate salt.
Mechanism Of Action and Pharmacodynamic Effects
Peginesatide is an erythropoietin receptor agonist. This drug mimics the structure of human erythropoietin in promoting red blood cell development.
External links